Get started
Author

Javier Ros

Observed names: F J Ros Montana, F.J. Ros Montana, F.J. Ros Montañá, Francisco J. Ros, Francisco Javier Ros Montaña, J. Ros, Javier Ros Montañá, Javier Ros-Montañá, Ros, Javier
Observed institutions: Universitat de Vic - Universitat Central de Catalunya, Universitat Autònoma de Barcelona, University of Campania "Luigi Vanvitelli", Hospital Universitario Puerta de Hierro Majadahonda, Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Cáncer, Vall d'Hebron Institute of Oncology
ORCID: 0000-0002-8137-5415
Observed ORCID: 0000-0002-8137-5415
OpenAlex ID: A5074495046
Sex and gender perspectives in colorectal cancer
2023 · I. Baraibar, J. Ros, et al. · ESMO Open · 121
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
2022 · Elena Elez, Javier Ros, et al. · Nature Medicine · 111
PDF
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria
2019 · Ignacio Matos, Juan Martin-Liberal, et al. · Clinical Cancer Research · 90
Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study
2021 · Yoshinori Kagawa, Elena Elez, et al. · Clinical Cancer Research · 78
PDF
The Evolving Treatment Landscape in BRAF-V600E –Mutated Metastatic Colorectal Cancer
2022 · Josep Tabernero, Javier Ros, et al. · American Society of Clinical Oncology Educational Book · 69
PDF
Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern
2019 · Ana Matas-García, José C. Milisenda, et al. · Autoimmunity Reviews · 69
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis
2023 · Iago Pinal-Fernandez, Angela Quintana, et al. · Annals of the Rheumatic Diseases · 64
PDF
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
2021 · Javier Ros, Iosune Baraibar, et al. · Therapeutic Advances in Medical Oncology · 64
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
2023 · Nadia Saoudi González, Francesc Salvà, et al. · Cancers · 63
PDF
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments
2023 · J. Ros, J. Matito, et al. · Annals of Oncology · 63
PDF
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
2023 · Javier Ros, Francesca Balconi, et al. · Frontiers in Oncology · 61
PDF
Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
2021 · Iosune Baraibar, Oriol Mirallas, et al. · Cancers · 60
PDF
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
2023 · Javier Ros, Iosune Baraibar, et al. · Cancers · 50
PDF
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
2020 · Giulia Martini, Rodrigo Dienstmann, et al. · Therapeutic Advances in Medical Oncology · 50
Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver
2024 · Javier Ros, Caterina Vaghi, et al. · International Journal of Molecular Sciences · 46
PDF
Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer
2024 · Nadia Saoudi González, Javier Ros, et al. · Cancers · 46
PDF
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
2023 · G. Martini, V. Belli, et al. · ESMO Open · 39
Liver transplantation in metastatic colorectal cancer: are we ready for it?
2023 · Javier Ros, Francesc Salva, et al. · British Journal of Cancer · 39
PDF
Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
2021 · Davide Ciardiello, Giulia Martini, et al. · Cancers · 35
PDF
Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report
2018 · Gerard Oristrell, Jordi Bañeras, et al. · European Heart Journal - Case Reports · 32
PDF
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer
2022 · Giacomo Mazzoli, Romain Cohen, et al. · European Journal of Cancer · 31
Treatment of BRAF-V600E mutant metastatic colorectal cancer: new insights and biomarkers
2023 · Javier Ros, Marta Rodríguez-Castells, et al. · Expert Review of Anticancer Therapy · 28
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
2023 · Vincenzo Nasca, Francesco Barretta, et al. · Journal for ImmunoTherapy of Cancer · 28
Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes
2019 · Albert Selva-O'Callaghan, Javier Ros, et al. · Neuromuscular Disorders · 28
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
2024 · C. Gallois, E.S. Bergen, et al. · ESMO Open · 25
PDF
Works count: 244
Citation count: 1,961
H-index: 25
I10-index: 50
Year
Topic
Type